Sep 30, 2017

Gilead Sciences Q3 2017 Earnings Report

Total Revenue
$6.51B
Previous year: $7.5B
-13.2%
EPS
$2.27
Previous year: $2.75
-17.5%
Gross Profit
$5.48B
Previous year: $6.37B
-14.0%
Cash and Equivalents
$11.5B
Previous year: $9.81B
+17.3%
Free Cash Flow
$2.57B
Previous year: $4.13B
-37.9%
Total Assets
$64.7B
Previous year: $56.6B
+14.2%

Gilead Sciences

Gilead Sciences